Form 6-K RedHill Biopharma Ltd. For: Apr 20
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
RedHill Biopharma (RDHL) Reports Q4 Loss of $0.04/Share
April 20, 2016 7:48 AM EDTRedHill Biopharma (NASDAQ: RDHL) reported Q4 EPS of ($0.04), versus ($0.05) reported last year.
For earnings history and earnings-related data on RedHill Biopharma (RDHL) click here.
... More